We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Catenae Innovation Plc | CTEA | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.55 | 00:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.55 | 0.55 |
| Industry Sector |
|---|
| MEDIA |
| Top Posts |
|---|
Posted at 27/3/2022 10:15 by peaky01 The type of response shows what a low level scum u really r. I am holding syme and will continue doin so BUT unlike u my point was i have never done on syme BB what u was doing here full well knowin the fate on way for ctea.U r scum |
Posted at 27/3/2022 10:00 by peaky01 Id rather be holding syme then the suspended ctea. |
Posted at 17/3/2022 20:27 by guy gibson CTEA is a unicorn. |
Posted at 17/12/2021 10:48 by david gruen Without giving too much away, unless CTEA breaches support at 0.340, I am in for the near/long term.If you think I'm some kind of mug punter that can't take a loss, you're wrong. In fact I cut my losses on SBTX only yesterday once support had been breached. At the end of the day, CTEA have a market cap of just over 2 million. Downside risk is negligible. Yes I could lose 100% of my investment, but that would be less than what I gained on BIDS and STX just this week. |
Posted at 17/12/2021 10:43 by pwhite73 DG - You can't be happy with a discounted placing if you're buying shares now. You can only be happy if you are partaking in the placing. A placing also signals a company is not generating sufficient income from its operations to keep the business running. We know this for a fact with CTEA because revenue to 31/03/2021 was only £12k.If you're honest with yourself and the rest of us what you're hoping for is an RNS out of the blue stating CTEA has been awarded a three year £10 million contract to supply services to company ABC. This would cause the shares to multi-bag pass any placing price and your current average holding price. That is what you are holding out for. However its not going to happen because CTEA does not have the infrastructure to take on any sizeable contracts or any contracts for that matter. |
Posted at 16/12/2021 09:16 by george gently More contracts coming for CTEA. Lots more. The sort that will send it up 10p in a day. Buy CTEA. |
Posted at 16/12/2021 08:35 by george gently More contracts coming for CTEA. You know, big ones. The sort that will send it up 10p in a day. Buy CTEA. |
Posted at 13/12/2021 18:27 by beeks of arabia There is no link from NHS data to the CTEA app, so not going to work.Besides, they'd just add the functionality to the NHS app, why use CTEA?!Is the government really desperate to work with a company like this with the revenue of a village chip shop? |
Posted at 09/12/2021 12:06 by david gruen CTEA is unlikely to single handedly cut a massive deal with a Government agency or organisation of similar size. They simply don't have the support or delivery capability to provide the required assurances to the buyer....but CTEA can partner with a large integrator who does have the capacity.A Capita, IBM, ATOS, or one of the other big players. For any of the aforementioned players to reach the stage CTEA are at currently could take months, and cost many millions. Many more millions than the CTEA cap currently. Just my view. |
Posted at 09/12/2021 10:23 by david gruen Are you really that thick Beeks? Or are you just playing on it?We're in the middle of a pandemic and CTEA have an APP/Testing combo on offer. "Catenae Innovation's Guy Meyer (LON:CTEA) and BHA Medical's Gavyn Hough talks to Proactive London after the announcement of their joint venture to deliver an integrated COVID-19 test. Meyer believes this partnership is strategically aligned and both counterparts complement each other's offering, with Catenae providing the technology part of this team. Hough explains their global role and in supplying 350,000 kits to date to FTSE 100 companies. He says: 'We have the science, they have the technology and as a solution that is a match made in heaven'." |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
